About US
Contact us
-
Top generics players and execs face DOJ investigation, charges: BloombergShare prices for leading generics companies took a big hit Thursday on news that the Department of Justice could file collusion charges by year’s end, a probe firstunveiledbyBloomberg. Companies incl2017/1/4
-
Why is Valeant's 'blockbuster' libido drug Addyi a dud? Shoddy marketing, investor lawsuit claimsWhen Valeant bought Sprout Pharmaceuticals and its controversial female libido drug Addyi, it agreed to a marketing blitz that would bring royalties to Sprout's former shareholders. Valeant bungled th2017/1/3
-
More Valeant up for bid? Beseiged pharma weighs $2.5B sale of eye-surgery bizAnother day, another Valeant asset sale rumor. Less than 24 hours after word got out that Valeant and Takeda were in Salix deal talks, the embattled drugmaker is said to be exploring a sale of its eye2017/1/3
-
Allergan to acquire Acelity’s regenerative medicine unit LifeCell for $2.9bnUS-based drugmaker Allergan has signed an agreement to acquire Acelity’s regenerative medicine unit LifeCell in a deal valued at $2.9bn. The acquisition will combine LifeCell's business, including it2016/12/30
-
AbbVie submits NDA to US FDA for pan-genotypic regimen of G/PGlobal biopharmaceutical company AbbVie has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its investigational, pan-genotypic regimen of glecaprevir / pibrenta2016/12/30
-
US FDA approves Rubraca to treat advanced ovarian cancerThe US Food and Drug Administration (FDA) has granted approval to Rubraca (rucaparib) for the treatment of advanced ovarian cancer in women. The poly ADP-ribose polymerase (PARP) inhibitor Rubraca is2016/12/29
-
Mylan launches authorised generic version of EpiPenUS-based Mylan has launched the authorised generic version of EpiPen (epinephrine injection, USP) auto-injector, after the recent price hike criticism. The self-injectable device (auto-injector) cont2016/12/29
-
CMA accuses Actavis UK of overcharging NHS for hydrocortisone tabletsThe UK’s primary competition and consumer authority CMA has accused Actavis of overcharging the NHS for hydrocortisone tablets. These tablets are used as the primary replacement therapy for people wh2016/12/28
-
UK researchers say saliva testing could form new tool to assess immunityResearchers from the University of Birmingham, UK, have revealed that testing antibody levels in saliva may offer a new way to check immunity to protect against bacterial infections. The researchers2016/12/28
-
GSK opens new global vaccines R&D centre in USGlaxoSmithKline (GSK) has opened its new global vaccines research and development (R&D) centre in Rockville, Maryland, as part of plans to expand its vaccines presence in the US. The company will2016/12/27